Dr. Jeremy S Duffield, MD PhD FRCP
VP of Research
Biogen, Cambridge
“’The role of perivascular cells in development, homeostasis and disease of the kidney”
Jeremy is a Physician Scientist and Nephrologist. He recently joined
Biogen in Cambridge Massachusetts as Vice President and Senior
Research Fellow in Discovery Research to help identify next
generation therapeutics in fibrogenesis and tissue repair, and to
grow the Tissue Injury and Fibrosis Therapeutic Area. He graduated
from Oxford and Edinburgh Universities, UK, and practiced
Nephrology in Edinburgh. From 2003, he directed the laboratory of
inflammation research as Assistant Professor at Harvard Medical
School, then as Associate Professor of Medicine & Pathology at the
University of Washington in Seattle. His laboratory has been focused
on the role of innate immune response cells in injury and repair and
on the role of pericytes and fibroblasts in microvascular remodeling
and fibrosis. Jeremy is a recipient of the Young Investigator Award
from the British Renal Association (2001) and Medical Research
Society (2002), NIDDK Young Investigator/Scholar Award (2010), and
the American Society of Nephrology Young Investigator Award
(2013). In 2011, he became an elected member of the American
Society for Clinical Investigation. He also serves on scientific study
sections at the NIDDK/NHLBI. He is a cofounder of Muregen, and has
served on advisory boards for Promedior Inc. and Regulus
Therapeutics; companies dedicated to the development of antifibrotic
therapies.
In his ‘spare’ time he races bicycles, climbs mountains, skis, plays
tennis, grows organic vegetables, looks after children (his own), and
fixes things that are broken.